August 2016 FDA Recall Drug by West-ward Pharmaceuticals Corp.
D-1515-2016 - Labeling
This Class III drug recall was voluntarily initiated by West-ward Pharmaceuticals Corp. on August 18, 2016 for the product Drug. The FDA reported the reason for recall as labeling. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1515-2016
Labeling: Label Error on Declared Strength- bottles missing colored coded panel where strength of the product is displayed.
08-18-2016
09-28-2016
32,006 bottles (AS1413A) and 32,198 bottles (AS1414A)
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
West-Ward Pharmaceuticals Corp.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
09-01-2017
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Amoxicillin For Oral Suspension, USP - Dye Free, 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, PO Box 182400, Amman 11118 - Jordan, Distributed by: West-Ward Pharmaceutical Corp. Eatontown, NJ 07724, NDC 00143-9887-01,
Batch or Lot Expiration Information
Lot# : AS1413A, AS1414A; Exp. 11/18